Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.

Dandan ZhaoXiaoxiao ZhangYuhui TangPeilin GuoRong AiMengmeng HouYiqi WangXiwei YuanLuyao CuiYuguo ZhangSuxian ZhaoWencong LiYang WangXiaoye SunLingdi LiuShiming DongLu LiWen ZhaoYuemin Nan

Published in: Journal of hepatocellular carcinoma (2022)

SHC1, SLAMF8 and IL-32 can differentiate among patients with HCC, LF/LC, CHB and healthy controls. More importantly, the APFSSI model greatly improves the diagnostic accuracy of HBV-associated liver diseases.

Keyphrases

liver fibrosis
single cell
hepatitis b virus
rna seq
gene expression
genome wide
liver failure
simultaneous determination
mass spectrometry
bioinformatics analysis
liquid chromatography